Grants and Collaborations


2017/19 Plan Cancer, "Integrating the intra-tumoral microbiome to promote understanding on tumor plasticity" (Mathias Chamaillard).

2017/19 FEDER (Mathias Chamaillard)

2016 Programme transversal Microbiote Inserm 2016 (Mathias Chamaillard)

2015/17 Association de Recherche contre le Cancer, "Impact of gut microbiota in the response to anticancer therapeutics" (Mathias Chamaillard)

2014/17 ANR, “STrepB17: Integrative Approach to identify environmental Risk Factors for CC-17 Group B Streptococcal neonatal infection” (ANR-13-PRTS-0006-03) (Mathias Chamaillard)

2014/17 ANR, “Combinnate: Gut Microbiota-Host Interactome in Response to Intestinal Pathogen” (ANR-13-BSV3-0014-02) (Mathias Chamaillard)

2013/16   Fondation pour la Recherche Médicale "Equipe FRM", "Multidisciplinary study of the interaction by the microbiota on the gut barrier function in Crohn’s disease and colorectal cancer" (Mathias Chamaillard)

2013/16   ANR, “BIOpaneX: a comprehensive screening for Paneth cell-targeting immunomodulatory drug applied to Crohn’s Disease” (ANR-12-RPIB-0014-01) (Mathias Chamaillard)

2013/16 Fondation pour la Recherche Médicale "Equipe FRM", "Multidisciplinary study of the interaction by the microbiota on the gut barrier function in Crohn's disease and colorectal cancer (Mathias Chamaillard).

2012/15 INCa, “Multidisciplinary study on the impact of the gut microbiota in a cognitive model of spontaneous colitis-associated colorectal cancer in mice” (Mathias Chamaillard).

2011/16 ATIP/Avenir (Lionel Poulin)

2010/12 Fondation pour la Recherche Médicale "Equipe FRM", "Microbiota and innate immunity: implications for Crohn’s disease" (Mathias Chamaillard)

2010/12 ARCIR – Feder, "Nod-like receptors and microbiota" (Mathias Chamaillard)

2010 Association de la Recherche pour le Cancer, " Immunité innée et tumorigénèse intestinale : une approche cognitive des cancers associées aux maladies inflammatoires chroniques du tube digestif " (Mathias Chamaillard)

2008/10 OSEO, "Dosage de peptides antimicrobiens par biopuce dans la Maladie de Crohn" (Mathias Chamaillard)

2008/10 Broad Medical Research Foundation, "Role of a c-type lectin on Nod2 signaling in Inflammatory Bowel Disease" (Mathias Chamaillard)

2009 Syndifrais (Industry), " Bactéries probiotiques et modulation de la réponse intestinale anti-microbienne " (Mathias Chamaillard)

2007/08 CNOUS, " Etude des variations génétiques et immunologiques chez les patients libanais atteints de la maladie de Crohn " (Mathias Chamaillard)

2007 FEDER, " Cellules régulatrices, infection et inflammation " (Mathias Chamaillard)

2006/10 Programme Hospitalier de Recherche Clinique, "Interface entre l’environnement microbien et la génomique fonctionnelle chez les patients atteints de maladies inflammatoires chroniques de l’intestin" (Mathias Chamaillard)

2006/07 Programme National de Recherche, "Respective role of innate and adaptive immune responses in ulcerative colitis: a collaborative study of the REMIND group" (Mathias Chamaillard)

2006 Lesaffre (Industry), "Etude du caractère probiotique de levures et/ou de produits dérives de levures" (Mathias Chamaillard)

2005 Association François Aupetit, " Étude du rôle physiologique de  NOD1/CARD4 au cours de la maladie de Crohn " (Mathias Chamaillard)

2005 Human Frontier, "Role of normal and mutant Nod2 in the host response to a Crohn's disease associated bacterium" (Mathias Chamaillard)